Anikeeva added, “Yes, it is a record-breaking particle, but it’s not as record-breaking as it could be.”
Although that is still a work in progress, the team has ideas about how to move forward.
Large-scale safety studies are one of the additional steps that would be necessary to move these nanodiscs from basic research using animal models to clinical use in humans, “which is something academic researchers are not necessarily most well-positioned to do,” according to Anikeeva.
Leave a reply